3 month vt3534 drgs edu and NF.lif_n944 cre+ drug 63x quali.tif

syn24987654

Created By Liyam Laraba liyamlaraba

studyId: syn22268652
studyName: The use of novel YAP/TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors
initiative: Young Investigator Award
fundingAgency: CTF

3 month vt3534 drgs edu and NF.lif_n944 cre+ drug 63x quali.tif page is loading…